Related Experiment Videos
Low dose oral methotrexate treatment of multiple sclerosis: a pilot study
R D Currier1, A F Haerer, E F Meydrech
1Department of Neurology, University of Mississippi Medical Center, Jackson 39216.
Journal of Neurology, Neurosurgery, and Psychiatry
|November 1, 1993
Abstract:
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.